Prosecution Insights
Last updated: April 19, 2026

Examiner: BELLAH, JEFFREY LAWRENCE

Tech Center 1600 • Art Units: 1683

This examiner grants 0% of resolved cases

Performance Statistics

%
Allow Rate
-60.0% vs TC avg
13
Total Applications
Interview Lift
1175
Avg Prosecution Days
Based on 0 resolved cases, 2023–2026

Rejection Statute Breakdown

7.7%
§101 Eligibility
21.5%
§102 Novelty
41.5%
§103 Obviousness
26.2%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18362074 METHODS AND COMPOSITIONS USING SINGLE STRAND ANNEALING PROTEINS Non-Final OA 10x Genomics, Inc.
17685033 METHODS AND COMPOSITIONS FOR MODIFYING PRIMARY PROBES IN SITU Non-Final OA 10x Genomics, Inc.
18203424 METHODS AND HYDROGEL COMPOSITIONS FOR PARTITIONING BIOLOGICAL SAMPLES Non-Final OA Bio-Rad Laboratories, Inc.
18269264 METHOD AND KIT FOR DETECTING TARGET NUCLEIC ACID FRAGMENT Non-Final OA Riken
18198443 NOVEL BIOMARKER FOR PREDICTING PROGNOSIS OF TREATMENT OF HER2-POSITIVE BREAST CANCER AND USE THEREOF Non-Final OA SAMSUNG LIFE PUBLIC WELFARE FOUNDATION
18356886 EXTRACELLULAR VESICLE PROTEOMIC BIOMARKER PANEL FOR OVARIAN CANCER SCREENING AND THE EARLY DETECTION OF DISEASE Non-Final OA University of Kansas
18010825 A METHOD OF SELECTIVELY CHARACTERISING A POLYNUCLEOTIDE USING A DETECTOR Non-Final OA Oxford Nanopore Technologies PLC
18468113 URINE PCR ASSAY AND USE THEREOF TO DIAGNOSE AND STAGE FELINE CHRONIC KIDNEY DISEASE Non-Final OA EDGE ANIMAL HEALTH, INC.
18344324 HIGH RESOLUTION MULTIPLEX METHOD FOR DETECTING AT LEAST TWO TARGETS WITH A DISTANCE OF BEYOND THE DIFFRACTION LIMIT IN A SAMPLE Non-Final OA Resolve Bio Sciences GmbH

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month